Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-470-3 | CAS number: 646-24-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute lethal oral dose (LD50) to mice for NMDA was determined to be 500 mg/kg bw. No fatalities occurred at the lower dose of 250 mg/kg. Inhalation and dermal studies were not conducted due to the corrosive properties of the substance.
The data justify the classification according to Regulation (EC) No 1272/2008 as Acute Tox. 4 (oral); H302, harmful if swallowed.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 Feb. 1996 to 8 Mar. 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- mouse
- Strain:
- other: SPF Crlj:CD1(ICR)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hino Breeding Center of Charles River Japan, Ltd.
- Age at study initiation: 8 days.
- Weight at study initiation: between 28 and 30g.
- Housing: in polycarbonate solid-floored cages with wood flakes (White Flake TM, Oriental Yeast Co., Ltd., Japan) in the animal room
- Diet (e.g. ad libitum): standard rodent diet (CRF-1 TM, Oriental Yeast Co., Ltd.) and drinking water provided ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 8 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 26 °C
- Humidity (%): 45-46%
- Air changes (per hr): 15 times
- Photoperiod (hrs dark / hrs light): Artificial lighting of the room was controlled to give a cycle of 12 hours continuous light and 12 hours continuous dark per 24 hours - Route of administration:
- oral: gavage
- Vehicle:
- other: Distilled water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 0 / 12.5 / 25 / 50 / 100 mg/mL.
- Amount of vehicle (if gavage): 0.1 mL/10 g bw
MAXIMUM DOSE VOLUME APPLIED: 1000 mg/kg bw - Doses:
- 0 / 125 / 250 / 500 / 1000 mg/kg bw.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations once in the morning and once in the evening. Weighing on days 0 (prior to dosing), 7 and 14.
- Necropsy of survivors performed: yes, a macroscopic examination, which consisted of opening abdominal and thoracic cavities. The macroscopic appearance of abnormal organs was recorded.
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: - Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 500 < mg/kg bw
- Based on:
- not specified
- Mortality:
- Mortality of the mice that received the test substance and their macroscopic findings were summarized in Table 2. Lethal toxicity to the mice was observed at the doses of 500 and 1000 mg/kg in early period (Day 0 – 3) after dosing.
- Clinical signs:
- other: Hemorrhage in stomach and intestine was observed in the mice that died on Day 0 – 1, and whitish foci were found on the liver of witch mice died on Day 1 – 3. Macroscopic abnormality was not found in all mice that survived at the end of study (Day 14).
- Gross pathology:
- No abnormalities were found in the mice dosed at 125 or 250 mg/kg throughout the study.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The acute lethal oral dose (LD50) to mice of the test substance was demonstrated to be greater than 250 and less than 1000 mg/kg in this study. A LD50 value of 500 mg/kg was taken as effect level based on the observed 50% survival rate at this dose level
- Executive summary:
This study was performed to evaluate the acute oral toxicity of nonane-1,9-diamine to mice. The male mice received a single oral gavage dose of the test substance at a dose level of 125, 250, 500 or 1000 mg/kg-bodyweight, and were observed for 14 days after dosing. Lethal toxicity was found at the dose levels of 500 and 1000 mg/kg. Hemorrhage in stomach and intestine was observed in the mice that died on Day 0 – 1, caused by the corrosion effects of the substance. Whitish foci were found on the liver of mice that died on Day 1 – 3. No abnormalities were found in the mice dosed at 125 or 250 mg/kg throughout the study. The acute lethal oral dose (LD50) to mice for NMDA was determined to be 500 mg/kg bw.
Reference
Table 2: Mortality after dosing of nonane-1,9-diamine and macroscopic organ findings in died during the observation period or killed on the study termination
Group [No. of micedosed] | Dose(mg/kg) | Mortality data | Organ findings/No. of mice showed the finding | %Mortality |
A [5] | 1000 | Two mice died on Day 0(the day of dosing). | Hemorrhage in stomach and intestine 2 | 100 |
Three mice died onDay 1. | Hemorrhage in stomachand in testine 3 Whitish foci on liver 3 | |||
No mouse survived onDay 14. | ||||
B [5] | 500 | Two mice died on Day1. | Hemorrhage in stomachand intestine 2]Whitish foci on liver[2] | 60 |
A mouse died on Day 3. | Whitish foci on liver[1] | |||
Two mice survived onDay 14. | No abnormal finding[2] | |||
C[5] | 250 | All mice survived onDay 14. | No abnormal finding[5] | 0 |
D [5] | 125 | All mice survived onDay 14. | No abnormal finding[5] | 0 |
E [ 5] | 0 | All mice survived onDay 14. | No abnormal finding[5] | 0 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 500 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The key acute oral study, conducted in similar to OECD 401, involved gavage administration. Male mice received a single oral gavage dose of the test substance at a dose level of 125, 250, 500 or 1000 mg/kg bodyweight, and were observed for 14 days after dosing. Lethal toxicity was found at the dose levels of 500 and 1000 mg/kg. Hemorrhage in stomach and intestine was observed in the mice that died on Day 0 – 1, and whitish foci were found on the liver of the mice which died on Day 1 – 3. No abnormalities were found in the mice dosed at 125 or 250 mg/kg throughout the study. The acute lethal oral dose (LD50) of the test substance was estimated to be greater than 250 and less than 1000 mg/kg. A LD50 value of 500 mg/kg was taken as effect level based on the observed 50% survival rate at this dose level.
Justification for selection of acute toxicity – oral endpoint
valid study with Klimisch 2 rating. No further studies were carried out due to highly corrosive proerties of the substance.
Justification for classification or non-classification
LD50 (500 mg/kg) for mouse has been accepted in place of rat for the purposes of classification. Reasons for this are:
i) To reduce the numbers of animals used for toxicity testing as the substance is corrosive.
ii) Current acute oral test methods allow the use of the mouse as an alternative rodent species (e.g. OECD Methods 420, 423 and 425).
An LD50 of 500 mg/kg bw meets the criteria for classification as Acute Tox. 4 (oral) according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.